- Ascendis Pharma (ASND) gained 7.5% amid some takeover speculation.
- There's talk that a Switzerland-based pharma company and another European firm are eyeing Ascendis (ASND), according to traders, who cited a Betaville "uncooked" alert that was circulating on Thursday.
- Betaville first reported last month that the Danish pharmaceutical firm may have attracted takeover interest.
- Ascendis (ASND) has a market cap of $13.3 billion.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.